MYRIAD GENETICS INC (MYGN)
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
DexCom, Inc. - Dexcom Further Advances Vision of Glucose Biosensing for All
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice
Expedia Group Research Finds Fully Connected Hotels Eliminate Friction and Improve Revenue Performance
U.S. Bank Names Eric Levine to Lead Healthcare Payments
GitLab Research Reveals Organizations Are Generating AI Code Faster Than They Can Control It
Telefónica Deutschland and Blue Planet Demonstrate How AI Agents Can Accelerate 5G Network Slicing Service Design
Introducing Allerium Coral: Defining the Next Phase of NG9-1-1
Equity Group Investments Exits its Investment in Cross Border Xpress
CoreWeave Named Official AI Cloud Partner of BattleBots